(Q42999360)

12 November 2017

title

Famciclovir in chronic hepatitis B: results of a dose-finding study (English)

1 reference

12 November 2017

1 reference

1 reference

C Trépo

1

1 reference

12 November 2017

P Jezek

2

1 reference

12 November 2017

G Atkinson

3

1 reference

12 November 2017

R Boon

4

1 reference

12 November 2017

C Young

5

1 reference

12 November 2017

publication date

1 June 2000

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

32

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

1011-1018

1 reference

Hepatitis B virus infection

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Famciclovir: review of clinical efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Quantitation of hepatitis B virus DNA in serum by ammonium sulfate precipitation and molecular hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Antiviral therapy of the Asian patient with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Hepatitis B reactivation after lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980106-3

7 January 2021

10.1016/S0168-8278(00)80106-3

Identifiers

DOI

1 reference

12 November 2017

1 reference